Weekly highlights from The Hive.
The Massachusetts Life Sciences Center has awarded $1.5 million in loans to local startups, including a company that uses silk proteins to preserve vaccines for global shipping without the need for cold storage.
The center, a quasi-public agency, provided $1 million to Vaxess Technologies, developer of the vaccine preservation system. That’s the most a single business can receive under the Accelerator Loan Program, which aims to help promising life-sciences companies speed up their development.
Consider that curable diseases still ravage remote parts of the world simply because it is difficult for aid groups to keep vaccines refrigerated in the field. Preserving immunizations with silk proteins, as Vaxess aims to do, could solve that problem.